305 filings
8-K
SABS
SAB Biotherapeutics Inc
15 Apr 24
Regulation FD Disclosure
5:15pm
8-K
SABS
SAB Biotherapeutics Inc
29 Mar 24
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
9:35am
8-K
SABS
SAB Biotherapeutics Inc
8 Mar 24
Entry into a Material Definitive Agreement
4:30pm
4
SABS
SAB Biotherapeutics Inc
23 Feb 24
SAB Biotherapeutics / Alexandra Kropotova ownership change
5:00pm
4
SABS
SAB Biotherapeutics Inc
23 Feb 24
SAB Biotherapeutics / Eddie Joe Sullivan ownership change
4:55pm
4
olxu2ud411
23 Feb 24
SAB Biotherapeutics / Christoph Lawrence Bausch ownership change
4:50pm
4
lrqgw
23 Feb 24
SAB Biotherapeutics / Michael King ownership change
4:45pm
4
5uh6n27cw3ww8 qnj
23 Feb 24
SAB Biotherapeutics / Samuel J Reich ownership change
4:40pm
S-8
53iovofnn 91s
23 Feb 24
Registration of securities for employees
4:18pm
SC 13G/A
fia6ukykbpcuuel mz
14 Feb 24
SAB Biotherapeutics / COMMODORE CAPITAL ownership change
4:05pm
SC 13G
e6sytli2
14 Feb 24
SAB Biotherapeutics / RTW INVESTMENTS ownership change
7:02am
SC 13G/A
zceckn0g wsysc96j
14 Feb 24
SAB Biotherapeutics / Radcliffe Capital Management ownership change
6:28am
8-K
xtswzoit7g1c6 ed1
2 Feb 24
SAB Biotherapeutics Announces Executive Leadership Change
7:53am
8-K
66kyqt70sobo
26 Jan 24
Entry into a Material Definitive Agreement
4:15pm
424B5
fgfkydo5uyh
26 Jan 24
Prospectus supplement for primary offering
4:00pm
8-K
8hnf3
25 Jan 24
Other Events
5:00pm
8-K
y4vri7 l9
19 Jan 24
Regulation FD Disclosure
4:21pm
8-K
pqlozbam
3 Jan 24
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
9:00am